Axsome Therapeutics, Inc. (AXSM)
NASDAQ: AXSM · Real-Time Price · USD
136.01
-8.42 (-5.83%)
At close: Nov 2, 2026, 4:00 PM EST
136.00
-0.01 (-0.01%)
After-hours: Nov 2, 2026, 7:40 PM EST
Axsome Therapeutics Employees
Axsome Therapeutics had 1,346 employees as of June 30, 2026. The number of employees increased by 500 or 59.10% compared to the same quarter last year. That makes Axsome Therapeutics the 12,790th largest employer in the world and 1,996th in the United States.
Employees
1,346
Change (1Y)
500
Growth (1Y)
59.10%
Revenue / Employee
$642,844
Profits / Employee
-$116,859
Market Cap
7.15B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 1,346 | 500 | 59.10% |
| Mar 31, 2026 | 1,220 | 508 | 71.35% |
| Dec 31, 2025 | 925 | 242 | 35.43% |
| Sep 30, 2025 | 816 | 209 | 34.43% |
| Jun 30, 2025 | 846 | 257 | 43.63% |
| Mar 31, 2025 | 712 | 143 | 25.13% |
| Dec 31, 2024 | 683 | 138 | 25.32% |
| Sep 30, 2024 | 607 | 105 | 20.92% |
| Jun 30, 2024 | 589 | 167 | 39.57% |
| Mar 31, 2024 | 569 | 176 | 44.78% |
| Dec 31, 2023 | 545 | 162 | 42.30% |
| Sep 30, 2023 | 502 | 150 | 42.61% |
| Jun 30, 2023 | 422 | 224 | 113.13% |
| Mar 31, 2023 | 393 | 277 | 238.79% |
| Dec 31, 2022 | 383 | 275 | 254.63% |
| Sep 30, 2022 | 352 | 246 | 232.08% |
| Jun 30, 2022 | 198 | 105 | 112.90% |
| Mar 31, 2022 | 116 | 46 | 65.71% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Ionis Pharmaceuticals | 1,480 |
| Corcept Therapeutics | 730 |
| Arrowhead Pharmaceuticals | 711 |
| ImmunityBio | 691 |
| Cytokinetics | 673 |
| Rhythm Pharmaceuticals | 414 |
| TG Therapeutics | 399 |
| Praxis Precision Medicines | 168 |
AXSM News
- 1 hour ago - Axsome Therapeutics price target lowered to $273 from $295 at RBC Capital - TheFly
- 2 hours ago - Axsome Therapeutics price target lowered to $239 from $256 at UBS - TheFly
- 8 hours ago - Axsome shares ‘significantly undervalued,’ says TD Cowen - TheFly
- 8 hours ago - Axsome Therapeutics price target lowered to $305 from $380 at Jefferies - TheFly
- 10 hours ago - Axsome Therapeutics price target lowered to $235 from $238 at Piper Sandler - TheFly
- 12 hours ago - Axsome Therapeutics reports Q3 EPS (25c), consensus (56c) - TheFly
- 12 hours ago - Axsome Therapeutics falls -10.9% - TheFly
- 15 hours ago - Axsome Therapeutics Earnings Call Transcript: Q3 2026 - Transcripts